Release 4B Snapshot 3: Connectathon 32 Base

This page is part of the Snapshot #3 for FHIR Specification (v4.3.0: R4B - STU ). The current version which supercedes this version is 5.0.0 R5 , released to support Connectathon 32 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0306

Example MedicationDispense/meddisp0306 (Narrative)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationDispense .


Generated Narrative Narrative: MedicationDispense

Resource MedicationDispense "meddisp0306"

status : in-progress

Medications

- medication : Reference
*

Resource "med0303"

code : Alemtuzumab 10mg/ml (Lemtrada) ( RxNorm #1594660)

subject : Patient/pat1: Donald Duck "Duck DONALD" "Donald DUCK"

Performers

- Actor
* Practitioner/f006 "Rob VAN DEN BERK"

authorizingPrescription : MedicationRequest/medrx0317

type : Daily Fill ( ActCode #DF)

quantity : 5(unit 415818006 from http://snomed.info/sct) (Details: SNOMED CT code 415818006 = 'Vial')

daysSupply : 7 Day (Details: UCUM code d = 'd')

whenPrepared : 2015-01-15T10:20:00Z

dosageInstruction

sequence : 1

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 3 per 1 weeks

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

dosageInstruction

sequence : 2

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 3 per 1 weeks

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

dosageInstruction

sequence : 3

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 3 per 1 weeks

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.